The Importance of Molecular Testing in the Treatment of Cholangiocarcinoma
Cholangiocarcinomas (CCA) are uncommon malignant tumours and are classified as intrahepatic, perihilar, or distal, depending on where they arise within the biliary epithelium. Surgery is still the only curative treatment, yet diagnosis is often made too late for this to be a viable option. For patie...
Main Authors: | David Malka, Alexander R. Siebenhüner, Joachim C. Mertens, Peter Schirmacher |
---|---|
Format: | Article |
Language: | English |
Published: |
European Medical Journal
2020-11-01
|
Series: | European Medical Journal Oncology |
Subjects: | |
Online Access: | https://www.emjreviews.com/oncology/article/the-importance-of-molecular-testing-in-the-treatment-of-cholangiocarcinoma/ |
Similar Items
-
Radiofrequency ablation via catheter and transpapillary access in patients with cholangiocarcinoma (ACTICCA-2 trial) – a multicenter, randomized, controlled, open-label investigator-initiated trial
by: Constantin Schmidt, et al.
Published: (2024-08-01) -
Current options and future directions of systemic therapy for advanced biliary tract cancer
by: Maria Giuseppina Prete, et al.
Published: (2021-10-01) -
Biliary adenofibroma: a precursor lesion of intrahepatic cholangiocarcinoma
by: Mayur Parkhi, et al.
Published: (2023-11-01) -
Overcoming treatment resistance in cholangiocarcinoma: current strategies, challenges, and prospects
by: Jiayi Wang, et al.
Published: (2024-08-01) -
Comprehensive molecular profiling of intrahepatic cholangiocarcinoma in the Chinese population and therapeutic experience
by: Longrong Wang, et al.
Published: (2020-07-01)